FI922454A0 - Peptider och antikroppar som inhiberar integrinligandbindning. - Google Patents

Peptider och antikroppar som inhiberar integrinligandbindning.

Info

Publication number
FI922454A0
FI922454A0 FI922454A FI922454A FI922454A0 FI 922454 A0 FI922454 A0 FI 922454A0 FI 922454 A FI922454 A FI 922454A FI 922454 A FI922454 A FI 922454A FI 922454 A0 FI922454 A0 FI 922454A0
Authority
FI
Finland
Prior art keywords
integrinligandbindning
inhiberar
antikroppar
peptider
som
Prior art date
Application number
FI922454A
Other languages
English (en)
Other versions
FI922454A (fi
Inventor
Edward F Plow
Souza Stanley E D
Mark H Ginsberg
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI922454A publication Critical patent/FI922454A/fi
Publication of FI922454A0 publication Critical patent/FI922454A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70557—Integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI922454A 1989-12-01 1992-05-27 Peptider och antikroppar som inhiberar integrinligandbindning. FI922454A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/444,777 US5196511A (en) 1989-12-01 1989-12-01 Peptides and antibodies that inhibit integrin-ligand binding
PCT/US1990/006954 WO1991007977A1 (en) 1989-12-01 1990-11-29 Peptides and antibodies that inhibit integrin-ligand binding

Publications (2)

Publication Number Publication Date
FI922454A FI922454A (fi) 1992-05-27
FI922454A0 true FI922454A0 (fi) 1992-05-27

Family

ID=23766316

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922454A FI922454A0 (fi) 1989-12-01 1992-05-27 Peptider och antikroppar som inhiberar integrinligandbindning.

Country Status (8)

Country Link
US (1) US5196511A (fi)
EP (1) EP0502124A4 (fi)
JP (1) JP3315403B2 (fi)
AU (1) AU645770B2 (fi)
CA (1) CA2069902A1 (fi)
FI (1) FI922454A0 (fi)
NO (1) NO922155L (fi)
WO (1) WO1991007977A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773574A (en) * 1990-12-03 1998-06-30 The Scripps Research Institute Polypeptides for promoting cell attachment
ATE184286T1 (de) 1991-04-30 1999-09-15 Scripps Research Inst Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
SK57693A3 (en) * 1992-06-18 1994-07-06 Merck Patent Gmbh Linear peptides and pharmaceutical agents on their base
US5453272A (en) * 1992-10-02 1995-09-26 Alberta Research Council Lectin derived carbohydrate binding-peptide
JPH08501569A (ja) 1992-10-02 1996-02-20 アルバータ リサーチ カウンスル 糖質結合ペプチドの抗炎症性、免疫寛容原性、および免疫阻害性
DE4310632A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Lineare Adhäsionsinhibitoren
US5594120A (en) * 1994-02-18 1997-01-14 Brigham And Women's Hospital, Inc. Integrin alpha subunit
US5523209A (en) * 1994-03-14 1996-06-04 The Scripps Research Institute Methods for identifying inhibitors of integrin activation
JPH09512021A (ja) * 1994-04-19 1997-12-02 ザ ユニバーシティ オブ カンサス Ｉｃａｍ−１／ｌｆａ−１ 短鎖ペプチドおよび該ペプチドの使用方法
US5610281A (en) 1994-05-03 1997-03-11 Brigham & Women's Hospital, Inc. Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
US5817750A (en) * 1995-08-28 1998-10-06 La Jolla Cancer Research Foundation Structural mimics of RGD-binding sites
EP0973797A4 (en) * 1996-04-26 2002-01-16 Univ Kansas PETPIDE COMPOSITIONS CAUSING IMMUNE TOLERANCE AND METHODS OF USE THEREOF
WO1998032771A1 (fr) * 1997-01-29 1998-07-30 Toray Industries, Inc. Proteines chimeres, complexes heterodimeres de ces proteines et substituant de plaquette
US6046316A (en) * 1997-12-09 2000-04-04 Wayne State University Nucleic acid encoding truncated integrins
US7618630B2 (en) * 1998-09-14 2009-11-17 Board Of Regents, The University Of Texas System Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
NZ528076A (en) * 2001-03-02 2005-09-30 Medimmune Inc Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists with an immunomodulatory agents, anti-inflammatory agents, TNF-alpha antagonists or CD2 binding molecules
AU2003213682C1 (en) * 2002-03-04 2008-06-12 Medimmune, Inc. Methods of preventing or treating disorders by administering an integrin alphavbeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
US20040001835A1 (en) * 2002-03-04 2004-01-01 Medimmune, Inc. Prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
EP1499352A4 (en) 2002-04-12 2006-10-11 Medimmune Inc ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES
US20040176272A1 (en) * 2003-01-30 2004-09-09 Medimmune, Inc. Uses of integrin alphavbeta3 antagonists
KR20120035234A (ko) 2003-04-11 2012-04-13 메디뮨 엘엘씨 재조합 ｉｌ?９ 항체 및 그의 용도
US7358331B2 (en) * 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
AU2005299355A1 (en) 2004-10-27 2006-05-04 Medimmune, Llc Modulation of antibody specificity by tailoring the affinity to cognate antigens
CN101124243A (zh) * 2004-12-23 2008-02-13 莫尔梅德股份有限公司 缀合产物
CA2629715C (en) * 2005-11-18 2016-05-03 Glenmark Pharmaceuticals S.A. Anti-alpha2 integrin antibodies and their uses
US8637469B2 (en) 2006-07-11 2014-01-28 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
US20080039362A1 (en) * 2006-08-09 2008-02-14 Afmedica, Inc. Combination drug therapy for reducing scar tissue formation
DK2068889T3 (da) 2006-08-10 2020-02-03 Roy C Levitt Anakinra til anvendelse i behandling af bronchiolitis obliterans syndrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion

Also Published As

Publication number Publication date
NO922155L (no) 1992-07-31
FI922454A (fi) 1992-05-27
NO922155D0 (no) 1992-05-29
JPH05502228A (ja) 1993-04-22
EP0502124A1 (en) 1992-09-09
AU6911391A (en) 1991-06-26
AU645770B2 (en) 1994-01-27
CA2069902A1 (en) 1991-06-02
EP0502124A4 (en) 1993-04-28
WO1991007977A1 (en) 1991-06-13
JP3315403B2 (ja) 2002-08-19
US5196511A (en) 1993-03-23

Similar Documents

Publication Publication Date Title
FI893105A (fi) Tryckkapsel foer spraybehaollare och spraybehaollare som utnyttjar en saodan kapsel.
FI903929A0 (fi) Proteiner som induserar immunologisk effektorcellaktivation och kemattraktion.
FI922454A0 (fi) Peptider och antikroppar som inhiberar integrinligandbindning.
FI906083A0 (fi) Foerbaettringar i cyklopeptidderivat och beroerande dessa.
FI902248A0 (fi) N-heteroaryl-4-kinolinaminer, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI911863A0 (fi) Metylendifosfonsyra och antiinflammatoriskt medel innehaollande denna foerening som aktivkomponent.
FI921279A0 (fi) Amino-b-lyasenzyminhibitorer som deodoranter.
FI900763A0 (fi) Tris-hydroximetyl-laegre alkanestrar som fettsurrogat.
FI892214A (fi) Kopparlegering foer anvaendning som motstaondssvetselektrod.
FI903214A0 (fi) Naftyl- och naftyloxi- pyrimidiner och dessa beroerande foereningar, foerfarande foer deras framstaellning och deras anvaendning som dermatologiska laekemedel.
FI895483A (fi) Som slaglod anvaendbara kopparblandningar.
FI905689A0 (fi) 3-aminopyrroler, foerfaranden foer deras framstaellning, och deras anvaendning som laekemedel.
FI904660A0 (fi) Som fungicider anvaendbara substituerade triazoler, deras framstaellning och kompositioner.
FI895749A0 (fi) Foerfarande och anordning i en pappersmaskin.
FI902852A0 (fi) Renininhibitoriska peptider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI901518A0 (fi) Stoetskyddbaerare foer doerrar och sidovaeggar i lastbilkarosserier.
FI902199A0 (fi) 5-substituerade 3-aryl-isoxazolderivat, deras framstaellning och deras anvaendning som skadedjursbekaempningsmedel.
FI900940A0 (fi) Tryckt kretsskiva som foerhindrar elektromagnetisk interferens.
FI905238A0 (fi) Foerbraenningsmotor foer fartyg som transporterar foerbraenningsgas.
FI901519A0 (fi) Stoetskyddbaerare foer doerrar och sidovaeggar i lastbilkarosserier.
FI892414A (fi) Foerfarande och anordning foer anvaendning som maol vid optisk skjutning.
FI905274A0 (fi) Katod som frigoer vaete.
FI901295A0 (fi) 2-halogencyklopropanderivat, foerfarande foer deras framstaellning och deras anvaendning som skadedjursutrotningsmedel.
FI910281A0 (fi) Kopplingsarrangemang som bildar triangelpuls.
FI904417A0 (fi) 2-fluorcyklopropylaettikasyraestrar, foerfaranden foer deras framstaellning och deras anvaendning som pesticider.

Legal Events

Date Code Title Description
FD Application lapsed